Annals of internal medicine

• Latest
• Best
• Search…

• Ann. Intern. Med. · Aug 2023

  Comment Letter

  The Complete Blood Count: Increasing Its Precision and Impact.

  no abstract available

  explore further… or not…

• Ann. Intern. Med. · Aug 2023

  Correction: Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.

  no abstract available

  expand abstract… or not…

• Ann. Intern. Med. · Aug 2023

  Annals On Call - When Might Genomic Screening Be Cost-Effective?

  no abstract available

  expand abstract… or not…

• Ann. Intern. Med. · Aug 2023

  New American College of Physicians Guidance on Colorectal Cancer Screening: Less Is More.

  no abstract available

  read on… or not…

• Ann. Intern. Med. · Aug 2023

  Comment Randomized Controlled Trial Multicenter Study

  In uncontrolled T2DM treated with a basal-bolus insulin regimen, weekly icodec was noninferior to daily glargine for HbA1c at 26 wk.

  Mathieu C, Ásbjörnsdóttir B, Bajaj HS, et al. Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial. Lancet. 2023;401:1929-1940. 37156252.

  keep going… or not…